Onasemnogene Abeparvovec Administration via Peripherally Inserted Central Catheter: A Case Report
Onasemnogene Abeparvovec Administration via Peripherally Inserted Central Catheter: A Case Report
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Onasemnogene abeparvovec (OA) is the approved intravenous gene therapy for the treatment of spinal muscular atrophy (SMA). A functional copy of the human SMN1 gene was inserted into the target motor neuron cells via a viral vector, AAV9. In clinical trials, OA was infused through a peripheral venous catheter, and no data are available on central ca...
Alternative Titles
Full title
Onasemnogene Abeparvovec Administration via Peripherally Inserted Central Catheter: A Case Report
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_8f349d5035a04bc69de3c05ac43b2ab3
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8f349d5035a04bc69de3c05ac43b2ab3
Other Identifiers
ISSN
2227-9067
E-ISSN
2227-9067
DOI
10.3390/children11050590
